269 results about "Ureter" patented technology

Intraoperative devices are described that assist the surgeon in identifying the location and characteristics of tissues and structures. Devices are also described that have the added capability of marking the location of the identified tissues and structures. This invention also includes devices that can selectively ablate adjacent tissues while avoiding damage and trauma to the identified tissues and structures by combining ablation with sensing, where sensing of either tissue properties, markings made by another device or surgeon, or a reference probe can be used. Devices are also described that protect tissue in the proximity of reference markings or probes by closed loop inhibition of the ablation process. The devices, systems, methods and kits described are adapted and configured to facilitate locating a target structure or target tissue within a body of a mammal, including nerves, peripheral nerves, blood vessels, and tubes such as the ureter. The devices, systems and methods may discriminate between different tissues by exploiting the electrical, mechanical, and physiological properties of the body.

The subject invention pertains to an elastic sheath, device, and methods for disrupting and / or removing occlusive material from lumens, particularly biological lumens, such as the vasculature, ureter, urethra, fallopian tubes, bile duct, intestines, and the like. The subject invention provides for effective disruption and removal of occlusive material, such as a thrombus, from the body lumen with minimal risk of injury to the lumen wall. Advantageously, the invention can be used to achieve a high degree of removal while minimizing the amount of occlusive material that is released into the body lumen. The subject invention further pertains to methods for disrupting and removing occlusive material from a biological lumen. In another aspect, the present invention concerns a device useful as an in vitro model of luminal occlusion and methods for using the device to test the efficacy of devices and methods for treating luminal occlusions.

A polymer of fluorinated monomers and hydrocarbon monomers is provided. It is also provided a polymer blend that contains a polymer formed of fluorinated monomers and hydrocarbon monomers and another biocompatible polymer. The polymer or polymer blend described herein and optionally a bioactive agent can form an implantable device such as a stent or a coating on an implantable device such as a drug-delivery stent, which can be used for treating or preventing a disorder such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, or combinations thereof.

It is a general object of the invention to provide a method of effecting tissue repair or replacement using a biomaterial. It is a specific object of the invention to provide a biomaterial suitable for use as a stent, for example, a vascular stent, or as a conduit replacement, as an artery, vein or a ureter replacement. The biomaterial can also be used as a stent or conduit covering or lining. The present invention relates to a method of repairing, replacing or supporting a section of a body tissue. The method comprises positioning a biomaterial at the site of the section and bonding the biomaterial to the site or to the tissue surrounding the site. The bonding is effected by contacting the biomaterial and the site, or tissue surrounding the site, at the point at which said bonding is to be effected, with an energy absorbing agent. The agent is then exposed to an amount of energy absorbable by the agent sufficient to bond the biomaterial to the site or to the tissue surrounding the site.

It is a general object of the invention to provide a method of effecting repair or replacement or supporting a section of a body tissue. Specifically to provide an elastin or elastin-based biomaterial suitable for use as a stent, for example, a vascular stent, or as conduit replacement, as an artery, vein or a ureter replacement. The biomaterial can also be used as a stent or conduit covering or coating or lining. It is also an object of the invention to provide a method of securing an elastin or elastin-based biomaterial to an existing tissue without the use of sutures or staples.

The present invention comprises a plurality of injectable hollow particulate fillers suspended in a biocompatible fluid carrier to significantly improve the clumping resistance and injectability of the composition. The hollow particulate fillers have a lower effective density and are able to suspend in the carrier without precipitation. The loss of skin volume as a result of aging, diseases, weight loss, and injury can lead to uneven skin surface (e.g. wrinkle, etc.). The uneven skin can be repaired by injecting appropriate amount of hollow fillers underneath the skin. Some cases of urinary incontinence occur when the resistance to urine flow has decreased excessively. Continence is restored by injecting the present invention to the urethra tissue to increase resistance to urine outflow. Similarly, the present invention allows for the control of gastric fluid reflux by submucosal injections of the fillers to the esophageal-gastric and gastric-pyloric junction. For patients with vesicoureteral reflux, it can be treated by injection of the present invention into patients' ureteral tissue. This invention can also be used to repair defective or inadequately functioning muscles of the anal sphincter by administering an effective amount of injectable hollow fillers into the defect or anal sinuses.

A medical device comprising a coating thereon comprising a biocompatible polymer and heparin is provided herein. Heparin is coupled with the biocompatible polymer via a spacer having a grouping that renders a binding site of the heparin molecule accessible by a binding protein. The medical device can be implanted in a human being for the treatment of a disease such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, or combinations thereof.

A hand-held disposable portable urinal device particularly well-suited for female use. The easy-to-use device has a leak and splash resistant soft upper seal attached to a retractable funnel, which easily folds back into a sealable bag. The funnel has a neck portion which allows the user to comfortably hold the urinal close to the ureter during use. The disposable urinal bag is odor- and vapor-sealable, and has a hydrophobic polymer containing inner bag for absorbing the urine. In addition, the disposable urinal has a deodorizer activated by the urine upon contact. The disposable urinal is easily transported in a folded state, and preferably comes three in a box. After use, the disposable urinal may be sealed and thrown away.

A system for removing a kidney stone from a ureter may include: an elongate, flexible, outer shaft having a distal end configured to be advanced into the ureter and a proximal end; an elongate, flexible, inner shaft extending through at least part of the outer shaft; an expandable stone retention member extending through at least part of the inner shaft and moveable along the longitudinal axis relative to the inner shaft; an elongate, flexible camera positioned coaxially within the retention member shaft, such that a distal end of the camera is located at or near a distal end of the inner shaft; and a handle coupled with the proximal end of the outer shaft, a proximal end of the inner shaft, and a proximal end of the retention member shaft.

A biodegradable double stent is used for various organs such as a biliary tract, an esophagus, an airway and a ureter. A biodegradable stent having a hollow cylindrical body woven out of a separate wire made of biodegradable polymer so as to have a plurality of rhombic spaces is fixed to an intermediate portion of a primary stent having a cylindrical body. When administered into the organ, the biodegradable stent has its original function of expanding the organ, and is firmly supported in the inner wall of a narrowed passage of the organ by pressurizing the inner wall of the narrowed passage of the organ. After a predetermined time period has elapsed, the biodegradable stent is gradually degraded away by bodily fluids, thereby enabling the primary stent to be easily removed from the organ.

Provided herein is an end-capped poly(ester amide) PEA) polymer and the method of making the polymer. The PEA polymer is substantially free of active amino end groups and / or activated carboxyl groups. The PEA polymer can form a coating on an implantable device, one example of which is a stent. The coating can optionally include a biobeneficial material and / or optionally with a bioactive agent. The implantable device can be used to treat or prevent a disorder such as one of atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, and combinations thereof.

Occluding structures may be created within a body lumen by advancing a length of material distally through the body lumen. By drawing a distal location on the advanced length of material in a proximal direction, the material may be compacted into a structure which at least partially occludes the lumen. The occluding structure may be used to remove kidney stones from the ureter in conjunction with lithotripsy and irrigation.

It is a general object of the invention to provide a method of effecting repair or replacement or supporting a section of a body tissue using tropoelastin, preferably crosslinked tropoelastin and specifically to provide a tropoelastin biomaterial suitable for use as a stent, for example, a vascular stent, or as conduit replacement, as an artery, vein or a ureter replacement. The tropoelastin biomaterial itself can also be used as a stent or conduit covering or coating or lining.

A uterine manipulator designed to perform a total laparoscopic hysterectomy in an easy, safe and effective manner, which simplifies the surgical procedure by improving the anatomical angle of access to round ligaments, salpinges, utero-ovarian ligaments, broad ligaments, uterine vessels, anterior endopelvic fascia, lateral endopelvic fascia, but very especially to the posterior endopelvic fascia due to innovative design of said manipulator that allows the anteversoflexion movement of uterus. In addition, the invention moves ureters away from the risk zone when tying the uterine vessels, and protects and prevents the mobilization of the bladder and rectum, as a result of improving the angle of access. Additionally, the manipulator has the advantage of being easily manageable because of the anatomical design of its handle and its strong design allows for total hysterectomy uterus, still too big and heavy uteri.

Provided herein is a PEA polymer blend and coatings or implantable devices formed therefrom. The PEA polymer blend is formed of a PEA polymer and a material capable of hydrogen bonding with the PEA. The PEA polymer blend can form a coating on an implantable device, one example of which is a stent. The coating can optionally include a biobeneficial material and / or optionally with a bioactive agent. The implantable device can be used to treat or prevent a disorder such as one of atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, and combinations thereof.

An apparatus is provided that includes an elongate member having a distal end portion, a proximal end portion, and a medial portion that is disposed between the distal end portion and the proximal end portion. The medial portion is configured to be disposed in a ureter of a patient. The apparatus further includes an expandable member that is coupled to the elongate member. The expandable member has an expanded configuration and a collapsed configuration. The expandable member is further configured to be inserted into the ureter of the patient and configured to contact the ureter to help retain the elongate member in place within the patient.

A method for removing a kidney stone from a ureter may involve: advancing a distal end of an elongate, flexible kidney stone removal device into the ureter to a location near the kidney stone; advancing an expandable stone retention member out of an inner shaft of the device; visualizing at least part of the stone retention member with a camera disposed coaxially within the stone retention member; trapping the kidney stone in the stone retention member; surrounding at least a portion of the stone retention member and the trapped kidney stone with a wall protection member on the distal end of the kidney stone removal device; and removing the kidney stone removal device from the ureter while the stone retention member and the kidney stone are at least partially surrounded by the wall protection member.

Implantable devices formed of or coated with a material that includes a polymer having a non-fouling acrylate or methacrylate polymer are provided. The implantable device can be used for treating or preventing a disorder such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, patent foramen ovale, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, or combinations thereof.

Occluding structures may be created within a body lumen by advancing a length of material distally through the body lumen. By drawing a distal location on the advanced length of material in a proximal direction, the material may be compacted into a structure which at least partially occludes the lumen. The occluding structure may be used to remove kidney stones from the ureter in conjunction with lithotripsy and irrigation.

A ureteral access sheath comprises a sheath assembly having a main lumen and one or more secondary lumens. The sheath assembly can be configured with medical devices in both lumens, for example, a ureteroscope in the main working channel, and a guidewire, stone basket, grasper, laser fiber, or other surgical instrument in the secondary working channel. Or the sheath assembly can be configured with a medical device in one channel and the other lumen coupled to an irrigation means, such that irrigation of the surgical field can be efficiently accomplished even though the main working channel is substantially completely occupied by, e.g., a ureteroscope. Or the sheath assembly can be configured for irrigation through one lumen and aspiration through the other lumen, thereby creating a turbulent flow which washes the surgical field to facilitate removal of particles and debris.

In one embodiment, the invention is directed to a stent retention element having an elastic member adapted to be incorporated with a first end of an elongate stent and to coil toward a second end of the elongate stent to anchor the elongate stent at an anatomical site. According to one feature, the stent retention element expands and compresses to effectively lengthen and shorten, respectively, the stent to accommodate ureter lengthening and shortening.

In accordance with some configurations, systems and methods for guided removal from an in vivo subject are provided. In some configurations, a method for removing an object is provided. The method comprising, guiding a flexible tube through an in vivo subject's ureter, wherein the flexible tube comprises at least a first passageway and a second passageway. Positioning a distal end of the first passageway adjacent to the object. Infusing saline solution through the second passageway while suction is off. Removing the object through the first passageway with at least a portion of the saline solution.

A biodegradable double stent is used for various organs such as a biliary tract, an esophagus, an airway and a ureter. A biodegradable stent having a hollow cylindrical body woven out of a separate wire made of biodegradable polymer so as to have a plurality of rhombic spaces is fixed to an intermediate portion of a primary stent having a cylindrical body. When administered into the organ, the biodegradable stent has its original function of expanding the organ, and is firmly supported in the inner wall of a narrowed passage of the organ by pressurizing the inner wall of the narrowed passage of the organ. After a predetermined time period has elapsed, the biodegradable stent is gradually degraded away by bodily fluids, thereby enabling the primary stent to be easily removed from the organ.

A sieving device and related methods including an expandable sieve mounted on a surgical guide wire. The expandable sieve may be a self-expandable braided filter which is mounted on the guide wire in an axially fixed position, or moveable in one or more directions. The sieving device is deployable in an obstructed ureter, or other body lumen, such as at the beginning of a stone removal procedure, prior to actual stone defragmentation (lithotripsy) phase. The expandable sieve may be set distal to the obstructive stone and expanded to span the entire local ureter cross section in order to retain stone fragments larger than a predetermined size from migrating distally towards the kidney under high irrigation rates / pressures during lithotripsy.

The present invention comprises a plurality of injectable hollow particulate fillers suspended in a biocompatible fluid carrier to significantly improve the clumping resistance and injectability of the composition. The hollow particulate fillers have a lower effective density and are able to suspend in the carrier without precipitation. The loss of skin volume as a result of aging, diseases, weight loss, and injury can lead to uneven skin surface (e.g. wrinkle, etc.). The uneven skin can be repaired by injecting appropriate amount of hollow fillers underneath the skin. Some cases of urinary incontinence occur when the resistance to urine flow has decreased excessively. Continence is restored by injecting the present invention to the urethra tissue to increase resistance to urine outflow. Similarly, the present invention allows for the control of gastric fluid reflux by submucosal injections of the fillers to the esophageal-gastric and gastric-pyloric junction. For patients with vesicoureteral reflux, it can be treated by injection of the present invention into patients' ureteral tissue. This invention can also be used to repair defective or inadequately functioning muscles of the anal sphincter by administering an effective amount of injectable hollow fillers into the defect or anal sinuses.

The invention provides a degradable expandable local urine tract intracavity support system to effectively support a local lesion urine tract after urine tract stricture obstruction surgery and to prevent stricture obstruction replase due to postoperation scar hyperplasia and contracture. The support system is made of degradable material and can be degraded after scar stability and before adhesive lithogenesis formation and can be discharged with urine outside the body; and the support system comprises but is not confined to a naked rack, a drug eluting stent or a drug coating layer rack, a film covering rack, etc. The support is compressed into an exotheca with small caliber and then released after reaching a target urine tract position, then expanded and enlarged to support the lesion urine tract; the internal diameter and length of the support can be adjusted according to clinic demands; and compared with traditional double J type ureter racks and catheters, interference and damage to normal urine tract except for the stricture part can be avoided, and limitation of rack lumen inner diameter by the urine tract physiological stricture part can be avoided.

The invention discloses a method for preparing the tube bracket restoring the tubular tissues and organs and its device. The oil soluble and water-soluble medicine or their mixture with two identical or different biological polymer solution through the single layer, inner and outer layer or compartment spinneret form the nanometer or micro fiber under the action of high voltage and static electricity, the fiber accumulates on the core rod to form the tube bracket restoring the tubular tissues and organs. The invention is characterized by the simple equipment, convenient operation and little energy consumption; the prepared tube bracket possesses larger degree of porosity; tubes of different inner diameter and thickness can be prepared by changing the electrical weaving to meet different needs; the medicine can be put into the tube at the time preparing the tubular bracket and can be released slowly in the tube. The tube bracket prepared in this invention can be used for the restoration of tubular tissure such as vessel, nerve, esophagus, tracheal and ureter.

A ureteral access sheath adapted for insertion into a urethra includes an elongate tube extending between a proximal end and a distal end. A handle assembly is disposed at the proximal end and includes enlarged portions which inhibit migration of the sheath into the urethra. The enlarged portions are shaped like the bell of a horn with a concave, distally-facing outer surface and a convex, proximally-facing inner surface. The inner surface functions as a funnel while the outer surface is sized and configured to receive adjacent fingers of a user's hand held in its natural position. In an associated method, this shape of the handle assembly facilitates maintaining the sheath in a stationary position during insertion and removal of instrumentation. The handle assembly can be movable on the tube to facilitate variation of the sheath link in situ.

The invention discloses a 3D kidney model printing method for kidney stone surgical simulation teaching. The printing method comprises the following steps: acquiring a high-density stone three-dimensional rebuilt model by utilizing MIMICS software by virtue of a scanning period of CTU, acquiring a three-dimensional rebuilt model of kidney skin and arteriovenous blood vessels by virtue of an arteriovenous enhanced period, acquiring a three-dimensional rebuilt model of pelvis and ureter by virtue of secretion enhanced period of pelvis, acquiring a kidney three-dimensional rebuilt model comprising kidney skin, kidney medulla, kidney artery and vein, pelvis and calices and ureter, and finally combining the three-dimensional rebuilt model of each part to obtain a complete kidney three-dimensional rebuilt model. By adopting the method, the problems that percutaneous nephrolithotomy is used as an effective and safe minimally-invasive surgery, to select an optimum puncture point is difficulty and a key point in the surgical operation, the formation of a three-dimensional image in the brain by virtue of a two-dimensional image needs long-term training and is prone to missing small dissection structures can be effectively solved.

The invention relates to the technical field of a medical instrument, particularly to ureteroscope with a flexible end and a retractable sheath, which is used for diagnosis and treatment of urinary system diseases. The ureteroscope comprises the retractable sheath (1) and an endoscope (2), wherein the retractable sheath (1) is a columnar hollow conduit provided with a retractable sheath handle (1.1) at the end above, a bushing port (1.2) matched with two limiting balls (2.3) on the endoscope (2) is arranged inside the retractable sheath handle, and the endoscope (2) is constituted by an eyepiece (2.7), a focal length adjusting knob (2.6), a light guide bundle interface (2.5), a gyration radius adjusting switch (2.8), a lens deflection direction adjusting knob (2.9) and a lens (2.4). The ureteroscope has the advantages that both the gyration radius and the bending angle of a flexible section (2.11) at the end of the endoscope can be adjusted according to needs so as to realize safe and efficient diagnosis and therapeutic surgery on the urinary system diseases related to ureter, pelvis and kidney calyces.